Charming Medical Limited · NASDAQ:MCTA
Charming Medical — IPO Roadshow (June 2025)
24 slides from Charming Medical's IPO roadshow presentation, Jun 3, 2025
Slide 1: Charming Medical Limited – June 2025 Issuer Free Writing Prospectus
Charming Medical Limited ( R e s e r v e d N a s d a q S y m b o l : M C TA ) June 2025 Issuer Free Writing Prospectus dated June 3, 2025 Filed Pursuant to Rule 433 of the Securities Act of 1933, as amended Relating to Preliminary Prospectus dated May 27, 2025 SEC Registration No.: 333 - 287258
Slide 2: Free Writing Prospectus Statement
This free writing prospectus relates to the proposed initial public offering of the Class A ordinary shares (the “Class A Ordinary Shares”), par value $0.0001 per share, of Charming Medical Limited (together with its subsidiaries, “we”, “us”, “the Group” and “our”, and should be read together with t
Slide 3: Forward-Looking Statements
Forward - Looking Statements 3 This presentation contains forward - looking statements. All statements contained in this presentation other than statements of historical fact, including statements regarding our future results of operations and financial position, our business strategy and plans, and
Slide 4: Offering Summary
Offering Summary 4 See offering documents for further details. There is no guarantee that any specific outcome will be achieved. Investments may be speculative, illiquid and there is a risk of principal loss. Charming Medical Limited Issuer Class A Ordinary Shares Securities MCTA Proposed Nasdaq Cap
Slide 5: Content
CONTENT 1 Company Profile 2 Business Strategies 3 Industry Overview 4 Financial Information 5 Management and Directors 5 See offering documents for further details. There is no guarantee that any specific outcome will be achieved. Investments may be speculative, illiquid and there is a risk of princ
Slide 6: Company Profile
Company Profile 1 6 See offering documents for further details. There is no guarantee that any specific outcome will be achieved. Investments may be speculative, illiquid and there is a risk of principal loss.
Slide 7: Corporate Overview
7 Corporate Overview Management and Directors Financial Information Industry Overview Business Strategies Company Profile We are committed to enhancing the quality of life from the inside out by integrating Traditional Chinese Medicine (TCM) wellness practices with modern technology. Through combini
Slide 8: Corporate History
8 Corporate History July 14, 2016 Pilate International Trading Limited was incorporated as a company with limited liability in Hong Kong. It engages in the business of providing wellness services. March 14, 2017 Dream International Trading (Hong Kong) Limited was incorporated as a company with limit
Slide 9: Customer service process
Reception 2 Upon the customer’s arrival, our staff will greet them, confirm appointment details, and guide them to the waiting area . We will then further assess their needs, expectations, and physical offer personalized condition to service recommendations. Consulting with a TCM Practitioner 4 Afte
Slide 10: Services and Products
Services and Products 2 4 3 1 We offer a wide range of TCM - inspired beauty, wellness, and postpartum therapies and products through our four wellness centers in Hong Kong. 4 n l l e W es s C e n t er s 2 P r od u c t Lines Beauty Lab brand offerings: TCM - inspired Supplements Products Uterine Car
Slide 11: Corporate Structure
Kit Wong Existing Minority Shareholders Public Shareholders Charming Medical Limited BVI Pilate International Trading Limited Hong Kong My Beauty Technology Limited Hong Kong Dream International Trading (Hong Kong) Limited Hong Kong Pre - IPO: 77.60% Class A and 100% Class B Ordinary Shares Post - I
Slide 12: Competitive Strengths: Professional team and certified services
Management and Directors Financial Information Industry Overview Business Strategies Company Profile Competitive Strengths Professional team and certified services We boast a team of professional TCM practitioners experienced in women's health and skilled technicians, offering comprehensive care and
Slide 13: Competitive Strengths: Quality assurance and TCM integration
Management and Directors Financial Information Industry Overview Business Strategies Company Profile Competitive Strengths High - quality assurance for products and services We are committed to delivering quality products and services while maintaining a satisfactory customer experience. • We implem
Slide 14: Business Strategies
Business Strategies 2 14 See offering documents for further details. There is no guarantee that any specific outcome will be achieved. Investments may be speculative, illiquid and there is a risk of principal loss.
Slide 15: Growth Strategies
Growth Strategies Management and Directors Financial Information Industry Overview Company Profile Business Strategies Expanding our presence in international markets We plan to increase international market share by entering new regions, adapting to local cultures and regulations, prioritiz ing hig
Slide 16: Industry Overview
Industry Overview 3 16 See offering documents for further details. There is no guarantee that any specific outcome will be achieved. Investments may be speculative, illiquid and there is a risk of principal loss.
Slide 17: Overview of Hong Kong's TCM Services Market
Overview of Hong Kong's Traditional Chinese Medicine (TCM) Services Market Financial Information Management and Directors Company Profile Business Strategies Industry Overview 32.5 30.2 32.8 32.6 36.9 39.2 41.9 45.2 48.4 51.3 54.3 57.3 Traditional Chinese Medicine Service Market Size in Hong Kong, 2
Slide 18: Overview and Scale of the TCM Beauty Market
Overview and Scale of the TCM Beauty Market 537.6 482.8 457.3 525.3 598.9 672.1 766.5 883.1 987.4 1,078.9 1,162.8 1,245.0 2019 2020 2021 2022 2023 2024E 2025E 2026E 2027E 2028E 2029E 2030E Market Size of TCM Beauty in Hong Kong, 2019 - 2030E 1 (HK$ billion) 2019 - 2023 CAGR 2.7% 2023 - 2030E CAGR 11
Slide 19: Financial Information
Financial Information 4 19 See offering documents for further details. There is no guarantee that any specific outcome will be achieved. Investments may be speculative, illiquid and there is a risk of principal loss.
Slide 20: Revenue and income for years ended March 31, 2023 and 2024
3,530,822 6,015,375 2023 2024 Revenue For the Years Ended March 31, 2023 and 2024 (Audited) (US$) Company Profile Business Strategies Industry Overview Management and Directors Financial Information 1,008,848 - 521,336 2023 2024 Income (Loss) from Operations 821,743 - 335,605 2023 2024 Net Income (L
Slide 21: Results for six months ended September 30, 2023 and 2024
Company Profile Business Strategies Industry Overview Management and Directors Financial Information 2,641,503 2,958,508 Revenue Income from Operations 443,686 554,849 2023 2024 Net Income mainly attributable to the increase in revenue generated from our provision of beauty, wellness and postpartum
Slide 22: Management
Management and Directors 5 22 See offering documents for further details. There is no guarantee that any specific outcome will be achieved. Investments may be speculative, illiquid and there is a risk of principal loss.
Slide 23: Management
Financial Information Management and Directors Kit Wong Director, Chief Executive Officer, and Chairman of the Board Ms. Wong has rich experience in postpartum repair, beauty and health, and TCM - inspired long - term health maintenance. She serves as the sole director of Pilate, My Beauty Technolog
Slide 24: Contact Us
24 Contact Us Issuer: Charming Medical Limited Email: corp@hkbeautylab.com Address: Units 1803 - 1806, 18/F, Hang Lung Centre, 2 - 20 Paterson Street, Causeway Bay, Hong Kong Underwriter: Cathay Securities, Inc. Email: service@cathaysecurities.com Address: 40 Wall Street, Suite 3600, New York, NY 10